Letters, Testimony & Comments
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 22 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
February 8 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
February 1 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
January 18 2013
The Biotechnology Industry Organization (BIO) is grateful for the opportunity to provide comments on India’s Draft National IPR...
November 8 2012
BIO supports the President’s decision to include Mexico in the TPP trade negotiations. Providing effective intellectual property...
September 4 2012
I. Agricultural and Animal Biotechnology
The Government of Canada has long been a trusted ally to the United States on agricultural...
September 3 2012
The Biotechnology Industry Organization (BIO) appreciates the U.S. Trade Representative's (USTR) query about BIO's views on how...
August 16 2012
The United States Patent and Trademark Office (USPTO) has led the world in providing technical expertise and training to various patent...
July 25 2012
The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to...
June 27 2012
The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
April 25 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
Priority...
February 14 2012
December 9, 2011
By Electronic Submission
To the State Intellectual Property Office,
The Biotechnology Industry Organization (BIO) appreciates this...
December 9 2011
By Electronic Submission
Ip.policy@uspto.gov
Office of Policy and External Affairs
United States Patent and Trademark Office...
November 10 2011
October 27, 2011
By electronic submission
Saurabh Vishnubhakat
Attorney Advisor,
Office of Chief Economist
United States Patent and Trademark...
October 27 2011
By electronic submission
Mr. Stan McCoy
Assistant USTR for Intellectual Property and Innovation
Office of the U.S. Trade...
October 20 2011
May 13, 2011
Dear Secretary Locke:
On behalf of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of...
May 13 2011
April 1, 2011
Re: Request for Comments on the Strategy for American Innovation
Subject: Innovation Strategy RFI
Email: competitiveness@doc.gov
Dear...
April 1 2011
February 15, 2011
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301 process and is hopeful that...
February 15 2011
November 22, 2010
RE: Participation of Malaysia in the Trans-Pacific Partnership Trade Negotiations
Dear Ms. Blue:
The Biotechnology Industry...
November 22 2010
October 14, 2010
October 14, 2010
To: Members of the Ad Hoc Open-ended Working Group on Access and Benefit-sharing of the Convention on Biological...
October 14 2010
September 29, 2010
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on India’s Department of Industrial...
September 29 2010
July 26, 2010
Biotechnology companies would be less likely to export their products into countries that do not provide meaningful IP and data...
July 26 2010
February 18, 2010
Intellectual Property
Innovation and Chair of the Special 301 Committee
Office of the United States Trade Representative
Washington, D...
February 18 2010
November 1, 2009
Dear Ms. Blue:
The Biotechnology Industry Organization (BIO) is submitting this letter in response to the request by the...
November 1 2009
July 31, 2009
VIEWS AND PROPOSALS
OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) AND
THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF...
July 31 2009
June 1, 2009
U.S. Department of State
June 1 2009
March 11, 2009
Office of the U.S. Trade Representative
March 11 2009
February 19, 2009
Office of the U.S. Trade Representative
February 19 2009
February 28, 2008
Re: Sugestões ao projeto de lei que dispõe sobre o access tos recursos genéticos e seus derivados
Dear Sir/Madam...
February 28 2008
February 11, 2008
Re: Special 301: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 73 Fed. Reg. 2958 (...
February 11 2008
February 11, 2008
Office of the U.S. Trade Representative
February 11 2008
January 1, 2008
BIO commends the IGWG for its work on a global strategy and plan of action that, according to its mandate, will aim at "securing an...
January 1 2008
August 16, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the U.S. Council for International...
August 16 2007
March 8, 2007
Office of the U.S. Trade Representative
March 8 2007
February 1, 2007
RE: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 72 Reg. 1033 (January 9, 2007)...
February 1 2007
October 23, 2006
To: Members of the TRIPS Council, World Trade Organization
From: The Presidents of the Biotechnology Industry Organization, BIOTECanada...
October 23 2006
September 18, 2006
Office of the U.S. Trade Representative
September 18 2006
August 28, 2006
To the State Intellectual Property Office of the People's Republic of China
August 28 2006
June 9, 2006
Dear Ambassador Schwab:
The Russian Federation's accession to the World Trade Organization (WTO) would be an
important step forward...
June 9 2006
March 24, 2006
Comments to the USTR touching on Intellectual Property Rights, Biosafety Protocol Implementation, Adventitious Presence, and Labeling.
March 24 2006
December 10, 2003
December 10 2003
February 14, 2003
Identifying countries of concern as per the Trade Act of 1974
February 14 2003
January 29, 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
January 29 2003
November 27, 2002
Letter to The Honorable Robert Zoellick, US Trade Representative
November 27 2002
RE: Notice of Public Hearing Concerning China's Compliance with WTO Commitments Written Comments (Federal Register Vol. 71, No. 145...
Every Year...
-of the 57 million people who die, 10.5 million are children under 5 years and 1.5 million are children between the ages...
Government's role in developing solutions for diseases that disproportionately affect developing countries
Introduction:
-...
National Institutes of Health: An International Perspective
NIH Mission:
To uncover new knowledge that will lead to improved public...
Innovation And The Global Research Enterprise
WORLD HEALTH ORGANIZATION
GENEVA—NOVEMBER 2007
THEODORE J. ROUMEL
VICE PRESIDENT...
Letters, Testimony & Comments
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
January 18 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
November 8 2012
The Biotechnology Industry Organization (BIO) is grateful for the opportunity to provide comments on India’s Draft National IPR...
Press Releases
February 21 2011
WASHINGTON, D.C. (Monday, February 21, 2011) - The Biotechnology Industry Organization (BIO) stresses the critical...
April 17 2007
WASHINGTON, D.C. (April 16, 2007) -- The following statement was issued today by Biotechnology Industry Organization...
Receive our newsletter from BIOtechNOW
Business Solutions Sponsor
